Expert Q&As
Launching in EU - Q&A 5
How should we plan our launch sequencing across European countries, considering timelines for approval, pricing, and access?
Access decades of experience
What’s Inside the Q&A:
Strategic Launch Sequencing
How to prioritize European markets for maximum early revenue and avoid costly timing mistakes.
Germany First Wave Strategy
Why Germany's unique reimbursement system makes it the optimal starting point for most launches.
Reference Pricing Navigation
Critical timing decisions that prevent low-price markets from undermining your premium pricing strategy.
Early Access Program Leverage
Parallel pathways to reach patients and generate revenue while formal pricing negotiations continue.
Download our expert answer
Discover our latest news
Expert Q&As
Launching in EU - Q&A 10
How can we leverage early access programs and real-world evidence (RWE) to support our European launch?
Expert Q&As
Launching in EU - Q&A 1
Why is launching a drug in Europe different from launching in the US?
Expert Q&As
Launching in EU - Q&A 2
How should we go about hiring and building a European presence?
